These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23236531)

  • 1. Clofazimine modulates the expression of lipid metabolism proteins in Mycobacterium leprae-infected macrophages.
    Degang Y; Akama T; Hara T; Tanigawa K; Ishido Y; Gidoh M; Makino M; Ishii N; Suzuki K
    PLoS Negl Trop Dis; 2012; 6(12):e1936. PubMed ID: 23236531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role of hormone-sensitive lipase (HSL) in the maintenance of lipid storage in Mycobacterium leprae-infected macrophages.
    Tanigawa K; Degang Y; Kawashima A; Akama T; Yoshihara A; Ishido Y; Makino M; Ishii N; Suzuki K
    Microb Pathog; 2012 May; 52(5):285-91. PubMed ID: 22553833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
    Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
    Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of constituents of MDT regimen for leprosy with Mycobacterium leprae HSP18: impact on its structure and function.
    Chakraborty A; Ghosh R; Biswas A
    FEBS J; 2022 Feb; 289(3):832-853. PubMed ID: 34555271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo interactions of drugs used in multidrug therapy in leprosy.
    Dhople AM; Lamoureux LC; Gardner GD
    Indian J Lepr; 1991; 63(2):166-79. PubMed ID: 1664440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of anti-leprosy drugs on superoxide anion production by rat peritoneal macrophage with special reference to light exposed clofazimine.
    Sahu A; Saha K; Banerjee NR; Sehgal VN; Jagga CR
    Int J Immunopharmacol; 1991; 13(4):419-28. PubMed ID: 1646774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The function of peroxisome proliferator-activated receptors PPAR-γ and PPAR-δ in Mycobacterium leprae-induced foam cell formation in host macrophages.
    Luo Y; Tanigawa K; Kawashima A; Ishido Y; Ishii N; Suzuki K
    PLoS Negl Trop Dis; 2020 Oct; 14(10):e0008850. PubMed ID: 33075048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and interactions of antileprosy drugs.
    George J
    Biochem Pharmacol; 2020 Jul; 177():113993. PubMed ID: 32339493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 10. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
    Matsuoka M; Kashiwabara Y; Namisato M
    Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of adipose differentiation-related protein (ADRP) and perilipin in macrophages infected with Mycobacterium leprae.
    Tanigawa K; Suzuki K; Nakamura K; Akama T; Kawashima A; Wu H; Hayashi M; Takahashi S; Ikuyama S; Ito T; Ishii N
    FEMS Microbiol Lett; 2008 Dec; 289(1):72-9. PubMed ID: 19054096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
    Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K
    Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of mutations in folp1, rpoB and gyrA genes of M. leprae by PCR- direct sequencing--a rapid tool for screening drug resistance in leprosy.
    Sekar B; Arunagiri K; Kumar BN; Narayanan S; Menaka K; Oommen PK
    Lepr Rev; 2011 Mar; 82(1):36-45. PubMed ID: 21644470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiolabeling of Mycobacterium leprae lipids within schwannoma cells, a potential drug screening system.
    Mistry Y; Antia NH; Mukherjee R
    Antimicrob Agents Chemother; 1991 Jul; 35(7):1444-7. PubMed ID: 1929306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multidrug-resistance to dapsone, rifampicin, and ofloxacin in Mycobacterium leprae.
    Cambau E; Perani E; Guillemin I; Jamet P; Ji B
    Lancet; 1997 Jan; 349(9045):103-4. PubMed ID: 8996430
    [No Abstract]   [Full Text] [Related]  

  • 16. The immunopharmacology of antileprosy agents.
    Anderson R
    Lepr Rev; 1983 Jun; 54(2):139-44. PubMed ID: 6350776
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular detection of multidrug-resistant Mycobacterium leprae from Indian leprosy patients.
    Lavania M; Singh I; Turankar RP; Ahuja M; Pathak V; Sengupta U; Das L; Kumar A; Darlong J; Nathan R; Maseey A
    J Glob Antimicrob Resist; 2018 Mar; 12():214-219. PubMed ID: 29097343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OFLOXACIN multicentre trial in MB leprosy FUAM-Manaus and ILSL-Bauru, Brazil.
    Cunha Mda G; Virmond M; Schettini AP; Cruz RC; Ura S; Ghuidella C; Viana Fdos R; Avelleira JC; Campos AA; Filho B
    Lepr Rev; 2012 Sep; 83(3):261-8. PubMed ID: 23356027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of rifampicin resistance and comparison of dapsone resistance of M. leprae in pre- and post-MDT era.
    Gupta UD; Katoch K; Katoch VM
    Indian J Lepr; 2009; 81(3):131-4. PubMed ID: 20509341
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Hungria EM; Bührer-Sékula S; Oliveira RM; Aderaldo LC; Pontes MAA; Cruz R; de Gonçalves HS; Penna MLF; Penna GO; Stefani MMA
    Front Immunol; 2018; 9():915. PubMed ID: 29867930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.